In this regard, a Japanese cohort revealed that the gain-of-function of the IL-1β-511C>T rs16944 variant plays a major role in the development of NAFLD through its involvement in disease stages ranging from simple steatosis’ progression toward NASH and fibrosis [149, 151]. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.